Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation

Journal of the American College of Cardiology

Volumn 38, Issue 3, 2001, Pages 814-818

  Weis, Michael ^a   Pehlivanli, Sinan ^b   Meiser, Bruno M ^b   Von Scheidt, Wolfgang ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; CYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; SIMVASTATIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CORONARY SINUS; ENZYME INHIBITION; EPICARDIUM; HEART PROTECTION; HEART TRANSPLANTATION; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASOMOTOR REFLEX;

CORONARY ANGIOGRAPHY; CYTOKINES; ENDOTHELIUM, VASCULAR; HEART; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INTERLEUKIN-2; INTERLEUKIN-6; MIDDLE AGED; SIMVASTATIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034840966     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01430-9     Document Type: Article

References (16)

1. Effects of pravastatin on outcome after cardiac transplantation
2. Simvastatin reduces graft vessel disease and mortality after heart transplantation: A four year randomized trial
3. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia
4. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
5. Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries
6. Coronary atherosclerosis in the transplanted heart
7. Cardiac allograft vasculopathy assessed intravascular ultrasonography and nonimmunologic risk factors
8. Hyperlipidemia after heart transplantation: Report of a 6-year experience, with treatment recommendations
9. Modulation of coronary vasomotor tone by cytokines in cardiac transplant recipients
10. Coronary vasomotor dysfunction in the cardiac allograft: Impact of different immunosuppressive regimens
11. Development of transplant vasculopathy and progression of donor-transmitted atherosclerosis: A comparison by serial intravascular ultrasound imaging
12. Effects of statins on vascular wall: Vasomotor function, inflammation, and plaque stability
13. Long-term effects of pravastatin on plasma concentration of C-reactive protein: The Cholesterol And Recurrent Events (CARE) Investigators
14. Vascular endothelium, hemodynamic forces, and atherogenesis
15. Coronary vascular reserve in humans: A critical review of methods of evaluation and of interpretation of the results
16. Intracoronary ultrasound imaging: Methods and clinical applications